CHC Healthcare Group (TPE:4164)
Taiwan
· Delayed Price · Currency is TWD 43.15
+0.35 (0.82%)
Apr 28, 2025, 1:35 PM CST
CHC Healthcare Group Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 3,601 | 3,877 | 2,974 | 2,440 | 2,555 | Upgrade
|
| Revenue Growth (YoY) | -7.13% | 30.35% | 21.92% | -4.52% | -13.39% | Upgrade
|
| Cost of Revenue | 2,841 | 2,809 | 2,072 | 1,590 | 1,724 | Upgrade
|
| Gross Profit | 759.13 | 1,068 | 902.31 | 849.48 | 830.71 | Upgrade
|
| Selling, General & Admin | 522.46 | 454.41 | 422.4 | 355.84 | 310.46 | Upgrade
|
| Research & Development | - | - | - | - | 6.25 | Upgrade
|
| Operating Expenses | 520.42 | 454.68 | 426.55 | 356.15 | 317.61 | Upgrade
|
| Operating Income | 238.71 | 613.48 | 475.76 | 493.33 | 513.1 | Upgrade
|
| Interest Expense | -87.58 | -77.34 | -58.89 | -50.18 | -65.43 | Upgrade
|
| Interest & Investment Income | 26.86 | 22.25 | 16.04 | 11.01 | 13.06 | Upgrade
|
| Earnings From Equity Investments | 1 | 1.6 | -0.33 | 8.64 | -0.28 | Upgrade
|
| Currency Exchange Gain (Loss) | 7.59 | -5.34 | 19.69 | 1.77 | -17.25 | Upgrade
|
| Other Non Operating Income (Expenses) | 37.28 | -7.14 | -6.24 | -4.16 | 21.48 | Upgrade
|
| EBT Excluding Unusual Items | 223.86 | 547.51 | 446.02 | 460.4 | 464.68 | Upgrade
|
| Gain (Loss) on Sale of Investments | 4.03 | 13.09 | -17.99 | -0.96 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 2.09 | -1.33 | 55.81 | 31.5 | -0.69 | Upgrade
|
| Other Unusual Items | -6.97 | 0.16 | - | 0.13 | 0.01 | Upgrade
|
| Pretax Income | 223.01 | 559.43 | 483.84 | 491.07 | 464 | Upgrade
|
| Income Tax Expense | 40.43 | 134.19 | 95.19 | 110.79 | 101.08 | Upgrade
|
| Earnings From Continuing Operations | 182.58 | 425.24 | 388.65 | 380.28 | 362.91 | Upgrade
|
| Minority Interest in Earnings | -14.19 | -6.37 | -32.08 | 1.35 | 3.48 | Upgrade
|
| Net Income | 168.38 | 418.87 | 356.57 | 381.63 | 366.39 | Upgrade
|
| Net Income to Common | 168.38 | 418.87 | 356.57 | 381.63 | 366.39 | Upgrade
|
| Net Income Growth | -59.80% | 17.47% | -6.57% | 4.16% | -7.28% | Upgrade
|
| Shares Outstanding (Basic) | 167 | 164 | 161 | 157 | 145 | Upgrade
|
| Shares Outstanding (Diluted) | 195 | 194 | 192 | 186 | 201 | Upgrade
|
| Shares Change (YoY) | 0.55% | 0.92% | 3.31% | -7.82% | 18.56% | Upgrade
|
| EPS (Basic) | 1.01 | 2.55 | 2.21 | 2.43 | 2.53 | Upgrade
|
| EPS (Diluted) | 0.98 | 2.26 | 1.98 | 2.18 | 1.95 | Upgrade
|
| EPS Growth | -56.59% | 14.30% | -9.38% | 11.66% | -20.57% | Upgrade
|
| Free Cash Flow | -331.72 | 412.92 | -25.97 | 178.7 | 194.77 | Upgrade
|
| Free Cash Flow Per Share | -1.70 | 2.13 | -0.14 | 0.96 | 0.97 | Upgrade
|
| Dividend Per Share | 1.510 | 2.010 | 1.968 | 2.011 | 2.010 | Upgrade
|
| Dividend Growth | -24.88% | 2.11% | -2.12% | 0.05% | 0.50% | Upgrade
|
| Gross Margin | 21.08% | 27.55% | 30.34% | 34.82% | 32.51% | Upgrade
|
| Operating Margin | 6.63% | 15.82% | 16.00% | 20.22% | 20.08% | Upgrade
|
| Profit Margin | 4.68% | 10.80% | 11.99% | 15.64% | 14.34% | Upgrade
|
| Free Cash Flow Margin | -9.21% | 10.65% | -0.87% | 7.32% | 7.62% | Upgrade
|
| EBITDA | 847.67 | 1,187 | 959.56 | 941.04 | 943.38 | Upgrade
|
| EBITDA Margin | 23.54% | 30.63% | 32.26% | 38.57% | 36.92% | Upgrade
|
| D&A For EBITDA | 608.96 | 573.89 | 483.8 | 447.71 | 430.28 | Upgrade
|
| EBIT | 238.71 | 613.48 | 475.76 | 493.33 | 513.1 | Upgrade
|
| EBIT Margin | 6.63% | 15.82% | 16.00% | 20.22% | 20.08% | Upgrade
|
| Effective Tax Rate | 18.13% | 23.99% | 19.67% | 22.56% | 21.79% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.